Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines.
In this episode, EIA Legal and Policy Specialist Avinash Basker talks to Senior Press & Communications Officer Paul Newman about the findings of our new report, Investing in Extinction, and the reputation risk to which major international household names might be exposing themselves by investing in this aspect of the traditional medicine industry.
Following the money – hitting the illegal wildlife trade where it hurts
Tipping the scales in our favour - the burning case for urgent action to tackle climate change
Not-so-fantastic plastic - why the world needs a global treaty to end plastic pollution
Is the coronavirus pandemic a warning to stop exploiting wildlife?
Why is Indonesia abandoning its timber export regulations?
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Advocacy Scoop Podcast
Social Dallas Podcast
Change Church Podcast
Six Degrees with Kevin Bacon
The Biz of Nonprofit Consultants